Airja

San Francisco, California, United States

PharmaTechPulmonary/ Asthma

We are a team of experienced professionals with over 50 years of combined pharmaceutical and entrepreneurial successes. Airja has patented technology with a fundamentally different approach to respiratory drug delivery. Our mission is to bring confidence, safety, accuracy, and convenience to drug delivery. — Airja's new generation of respiratory drug delivery solutions —Pharmaceutical Technology:• Precise aerosol particle size control ensuring deep lung delivery and rapid pharmacokinetics. • Immediate treatment for indications such as pain, panic, migraine, insomnia.• Delivery of compounds currently only available as injections.• Simplified development of dose form, removes issues with dry powder (DPI’s) and metered dose inhalers (MDI’s).• Extends patent life for soon to come off patented compounds.Cannabinoid Vape Solution:• No wick, no leaking.• Reservoir isolated from the heater, protecting extract from thermal decomposition. • Microprocessor controlled pump. • Proprietary heating system.• Precise, reliable, and consistent dose.• 5x vapor production capability.• Flavor retention across the life of the cartridge.• Capability for micro-dosing and larger volumes of vapor. For licensing opportunities, investment, or joint development inquiries, please contact Beverly Connelly through email — b.connelly@airjatech.com